Related Experiment Video
Updated: Jul 4, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Management of retroperitoneal sarcomas
Matthew T Hueman1, Joseph M Herman, Nita Ahuja
1The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
The Surgical Clinics of North America
|June 3, 2008
Summary
Retroperitoneal sarcomas are challenging tumors. While surgery offers the best chance for cure, local recurrence and distant metastasis remain significant issues impacting patient survival.
Area of Science:
- Surgical Oncology
- Medical Oncology
- Sarcoma Research
Background:
- Retroperitoneal sarcomas pose significant therapeutic challenges due to their anatomical location and invasive nature.
- High rates of local recurrence are observed even after aggressive surgical intervention.
- Distant metastatic disease is a major determinant of survival, particularly in high-grade lesions.
Purpose of the Study:
- To outline the current understanding of retroperitoneal sarcoma presentation.
- To detail the diagnostic evaluation process for these tumors.
- To describe contemporary management strategies for retroperitoneal sarcoma.
Main Methods:
- Review of clinical presentation characteristics.
- Discussion of diagnostic imaging and biopsy techniques.
- Analysis of surgical and adjuvant treatment modalities.
Main Results:
- Surgical resection is the cornerstone of potentially curative treatment.
- Local recurrence rates remain high despite optimal surgical techniques.
- Management requires a multidisciplinary approach to balance disease control and treatment morbidity.
Conclusions:
- Optimizing disease control while minimizing treatment-related morbidity is the primary goal.
- Multidisciplinary care is essential for effective retroperitoneal sarcoma management.
- Further research into novel therapeutic strategies is warranted to improve outcomes.
